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Ethnopharmacological  relevance:  Pyrostegia  venusta  is a native  Brazilian  plant  which  has  a  variety  of uses  in
traditional  folk  medicine  including  the  treatment  of  vitiligo.  However,  its  effectiveness  on  melanogenesis
is  not  yet  elucidated.
Aim of  the  study:  This  study  aimed  to investigate  the  melanogenic  activity  of  hydroalcoholic  extracts  from
the leaves  and  ﬂowers  of P. venusta  on  murine  B16F10  melanoma  cells.
Materials and  methods:  Different  concentrations  of  the  hydroalcoholic  extracts  of  ﬂowers  and  leaves  of  P.
venusta  were  evaluated  in  trials  of  spontaneous  melanin  content  (4 days),  and  cell  viability  by  the MTT
assay  in  murine  B16F10  cells,  and  in  the  mushroom  tyrosinase  activity  in  vitro.
Results:  Both  extracts,  leaves  (0.1;  0.3;  1  and  3  g/mL)  and  ﬂowers  (0.03  and  0.1 g/mL)  increased  the
melanin  content  in a concentration  dependent  manner  after  4 days  of incubation  on melanoma  cells.
Leaves  extract  promoted  enhancement  of  melanogenesis  with  maximum  effect  of 33.3  ± 3%  (3 g/mL),
and the  ﬂower  extract  increased  in 23.4  ± 3%  (0.1 g/mL).  The  cell viability  test  using  MTT  showed  that  in
the same  tested  concentrations  of  both  extracts  no cell  death  was  detected.  Actually,  either  extract  was
not able  to  cause  any  change  in  the  tyrosinase  activity.  HPLC  analysis  of P.  venusta  extracts  found  0.09%
and  1.08%  of allantoin  on  leaves  and  ﬂowers  extracts,  respectively.
Conclusions:  The  leaves  and  ﬂowers  extracts  of  P.  venusta  stimulates  B16F10  melanogenesis  at  very
low  concentrations.  These  ﬁndings  support  the  folk  medicinal  use of  P. venusta  on  the  treatment  of
hypopigmentation  diseases,  such  as vitiligo.. Introduction
Pyrostegia venusta (Ker Gawl.) Miers (Bignoniaceae) is a native
oody vine widely spread in Brazil which is specially found
hroughout ﬁelds, at coast, edge of the woods and along roadsides.
opularly known as “ﬂame vine” or “cipó-de-são-joão”, this species
s cultivated on account of outstanding ornamental features and on
ts important therapeutic properties (Lorenzi and Souza, 1995). P.
enusta leaves and stems are used in folk medicine as a tonic or
ntidiarrheal agent, while its ﬂowers are used in the treatment of
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ade  Estadual de Ponta Grossa, Campus Uvaranas, Av. General Carlos Cavalcanti
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white patches on the body, such as leucoderma and vitiligo. Besides
it is also used in cough and common diseases of the respiratory sys-
tem related to infections, such as bronchitis, ﬂu and cold (Ferreira
et al., 2000; Scalon et al., 2008; Veloso et al., 2010). Roy et al. (2011)
demonstrated that the extracts of ﬂowers and roots of P. venusta
contain signiﬁcant amounts of phytochemicals with antioxidative
properties that could act as inhibitors or scavengers of free rad-
icals. Moreover, no genotoxic effect was observed for extracts of
P. venusta on bone marrow of mice using the micronucleus and
chromosome aberration assay (Magalhães et al., 2010). Therefore,
P. venusta could be exploited as a potential source for plant-based
pharmaceutical products. Despite of its known popular use for the
treatment of vitiligo, there are no reports in the literature concern-
ing this property.
Open access under the Elsevier OA license.Disorders of pigmentation can result from abnormalities of
melanocytes (the cells responsible for skin pigmentation) migra-
tion from the neural crest to the skin during embryogenesis, as
well as from immunologic or toxic destructions of melanocytes
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Cardinali et al., 2005). More than 100 genes are involved in the
rocess of melanogenesis, encoding important structural, enzy-
atic and regulatory proteins (Bennett and Lamoreux, 2003).
yrosinase is known to play an important role in the regula-
ion of melanogenesis (Hearing, 1999), once it is responsible by
elanin synthesis which starts with the hydroxylation of l-tyrosine
o l-dihydroxyphenylalanine (DOPA), which is followed by the
xidation of DOPA to DOPA quinone (Jimenez-Cervantes et al.,
993). The DOPA quinone conjugated is progressively transformed
nto reddish-yellow pheomelanins, or used to the synthesis of
rownish-black eumelanins. Once formed, the melanin is pack-
ged in vesicles called melanosomes and then transferred to
eratinocytes through the dendritic tips of melanocytes, resulting
n the distribution of melanin throughout the epidermis. Impair-
ent of melanosome transfer to the surrounding keratinocytes,
n alteration in melanin synthesis and a defective degradation
r removal of melanin may  lead to abnormal skin pigmentation
Cardinali et al., 2005).
The most common hypopigmentant skin disorder is vitiligo,
hich is an autoimmune-induced depigmentation disease (Fistarol
nd Itin, 2010). Vitiligo affects 1–2% of the world population and
t is characterized by the destruction of melanocytes, promoting
mooth formation of white patches in the midst of the normally
igmented skin which usually initiates on the hands and feet and
hen spreads to several parts of the body (Abu Tahir et al., 2010;
istarol and Itin, 2010). Besides skin manifestation, vitiligo pro-
otes profound effect on people quality of life (Radtke et al., 2010;
alsania et al., 2010). Symptoms such as depression, sleep distur-
ances, suicidal thoughts and anxiety are very common in people
ffected by this disease (Szczurko and Boon, 2008). Vitiligo is ini-
ially treated with corticosteroids, immunomodulators, ultraviolet
adiation, lasers, alternate therapy, depigmentation and camou-
age. When classical interventions fail, vitiligo becomes refractory
nd stable, surgical proceedings with melanocytes transplanta-
ion are indicated. Therefore, several alternative methods, such
s topical or systemic tyrosine, cysteine, vitamins, clofazimine,
hinese herbal medications, ayurvedic medicine and others, have
een investigated and attempted with variable success, although
ometime with undesirable side effects (Falabella and Barona,
009).
Since ethnopharmacological information represents a great
hortcut in the search for new effective therapies, the aim of
his work was to investigate the activity of leaves and ﬂow-
rs of P. venusta in melanogenesis process on murine B16F10
elanoma cells, in order to support its popular use on vitiligo
reatment.
. Materials and methods
.1. Chemicals and reagents
Allantoin (98.0%) was purchased from Sigma–Aldrich (St. Louis,
O, USA), while methanol, acetonitrile (HPLC grade) and ethanol
analytical grade) were purchased from J. T. Baker Chemicals
. V. (Deventer, the Netherlands), and potassium dihydrogen
hosphate from Merck (Frankfurt, Germany). Ultrapure water
as obtained using a Milli-Q puriﬁcation system from Millipore
Bedford, MA,  USA). Penicillin/streptomycin was purchased from
nvitrogen. Mushroom tyrosinase, 3-(4,5-dimethylthiazol-2-yl)-
,5-diphenyltetrazolium bromide (MTT), l-tyrosine and dimethyl
ulfoxide were purchased from Sigma–Aldrich (St. Louis, MO,  USA).
ulbeccoıˇs modiﬁed Eagleıˇs medium (DMEM) and fetal bovine
erum were obtained from Cultilab (Brazil). Sodium hydroxide was
urchased from Biotec and kojic acid, from Galena (Campinas, SP,
razil).macology 141 (2012) 1005– 1011
2.2. Botanical material
Leaves and ﬂowers of P. venusta were collected in July 2008 in the
city of Colombo (coordinates: S 25◦19′16′ ′; W 49◦09′31′ ′), Paraná,
Brazil. The specie was identiﬁed by Osmar dos Santos Ribas from
Municipal Botanic Museum of Curitiba (MBM). A voucher specimen
(number 338804-02) was deposited at MBM  of Curitiba, Paraná,
Brazil.
2.3. Extracts obtention
Leaves and ﬂowers of P. venusta (100 g, each) were air dried
(40 ◦C, forced ventilation), powdered and extracted separately with
ethanol:water (70:30, v/v) by turbolysis (Ultra Turrax Biotrona
BA 80, Kinematica AG) at room temperature for 2 h. Hydroalco-
holic extracts (HE) were ﬁltered through a ﬁlter paper (Adventec
No. 1) followed by solvent reduction to 1/6 of the initial volume
under reduced pressure, lyophilized and kept at −20 ◦C until further
investigations. Before the pharmacological assays the lyophilized
HE was  dissolved in distilled water and ethanol to produce different
concentrations depending upon the assay performed.
2.4. Cell culture
Murine B16F10 melanoma cell line was  cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 10% fetal bovine
serum and 1% penicillin/streptomycin (10 000 U/100 g/mL) at
37 ◦C with 5% CO2 in a humidiﬁed atmosphere.
2.5. Cell viability assay
Cell viability after treatment with tested extracts was
determined using 3-(4, 5-dimethylthiazol-2-yl)-2,5 diphenylte-
trazolium bromide (MTT; Sigma Chemical Co., St. Louis, USA)
according to the method of Tada et al. (1986).  Brieﬂy, 7 × 103 cells
were added in each well of a 96-well plate. After 24 h, cells were
exposed to extracts of the P. venusta at several concentrations for
96 h. MTT  solution was added and cell viability was then assessed in
a colorimetric assay through mitochondrial dehydrogenase activ-
ity in active mitochondria to form purple formazan. Absorbance of
each well was read at 570 nm using a plate reader (EL808B, BioTech
Instruments, Inc., Winooski, VT, USA).
2.6. Determination of melanin content in melanocytes
Extracts inﬂuence on the production of melanin in melanocytes
was determined using the modiﬁed method of Tsuboi et al. (1998).
Cells were added into the wells of a 24-well plate (4 × 104 cells
per well). After 48 h, different concentrations (0.01–3 g/mL) of
the HE (ﬂowers and leaves), and kojic acid (1 mM,  as a reference
drug) were added to the cells and incubated at 37 ◦C in 5% CO2,
humidiﬁed atmosphere for 4 days. Control group was incubated
just with DMEM or DMEM plus extract vehicle (0.02% ethanol).
Then, the medium was  removed and cells were lysed with 500 L
of NaOH 1 N in 10% DMSO at 80 ◦C for 1 h. The relative melanin
content was  determined by measuring the absorbance at 490 nm
in a plate reader (EL808B, BioTech Instruments, Inc., Winooski, VT,
USA).
2.7. Mushroom tyrosinase activity assay
Tyrosinase activity was  determined according with the method
of Hyun et al. (2008) with modiﬁcations. In a 96-well microplate
were added: HE (ﬂowers and leaves) at different concentrations
(0.01–3 g/mL), 20 L of mushroom tyrosinase (500 U/mL in phos-
phate buffer, pH 6.5), 170 L of a mixture [l-tyrosine solution
opharmacology 141 (2012) 1005– 1011 1007
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Fig. 1. Effects of leaves and ﬂowers of Pyrostegia venusta on melanin content in cul-
tured B16 murine melanoma cells. B16 cells were incubated for 96 h in the presence
of  leaves (A) or ﬂowers (B) extracts at different concentrations. Kojic acid was usedC.G. Moreira et al. / Journal of Ethn
 mM,  potassium phosphate buffer 50 mM/pH 6.5, and distilled
ater (10:10:9, v/v/v), respectively]. Microplate was  incubated at
7 ◦C for 40 min  and the absorbance of the mixture was measured
t 490 nm using a microplate reader (EL808B, BioTech Instru-
ents, Inc., Winooski, VT, USA). One unit (U) of enzymatic activity
as deﬁned as the amount of enzyme needed to increase the
bsorbance at 280 nm by 0.001 per min, in a 3 mL  reaction mix-
ure containing l-tyrosine at pH 6.5 and 25 ◦C. The value of each
easurement was expressed as percentage changes from the con-
rol (reaction mixture without HE). Wells with HE diluted in buffer
ithout tyrosinase was carried out to exclude plant extract colour
nterference in the absorbance measurement.
.8. Allantoin content determination
The allantoin content on HE of P. venusta was  determined by
PLC analysis on an Agilent 1100 LC system (Wilmington, USA),
onsisting of a G1311A quaternary pump, a G1379A degasser, a
1329A automatic injector, a G1315B diode array detector and a
C workstation equipped with the Chemistation A.10.02 software
ackage for data collection and exploration. Chromatographic sep-
rations were carried out on a Zorbax NH2 (Agilent Technologies
nc., California, USA) 250 × 4.6 mm  i.d., 5 m particle size column
onnected to a pre-column Zorbax NH2 (Agilent Technologies Inc.,
alifornia, USA) 12.5 × 4.6 mm i.d., 5 m particle size, maintained
t room temperature. The column was eluted with a binary gra-
ient system consisting of acetonitrile and potassium phosphate
uffer (10 mM)  at ﬂow rate of 1.0 mL/min. The elution started with
0% of acetonitrile and decreased to 50% in eight min; follow to 0%
n 2 min  and returning to initial conditions in 2 min. The injection
olume of the sample was 10 L. The detection wavelength was
et at 220 nm.  Mobile phase were ﬁltered through a 0.45 m PTFE
embrane (Millipore, Molsheim, France).
For HPLC analysis samples of HE (1000 mg)  were redissolved
n 10 mL  of potassium dihydrogen phosphate buffer (10 mM)  and
onicated in an ultrasonic bath for 30 min. After centrifugation
3500 rpm, 10 min) samples were puriﬁed by solid phase extraction
SPE), through a SPE cartridge (LC-18 500 mg/3 mL,  Macherey-
agel) previously activated with methanol (3 mL)  and then washed
ith water (3 mL). After addition of samples (1 mL), the cartridges
ere eluted with 5 mL  of potassium dihydrogen phosphate buffer
nd transferred to a 10 mL  volumetric ﬂask that was ﬁlled with
he same solution. The resulting solution was  ﬁltered through a
olyvinylidene ﬂuoride (PVDF) syringe ﬁlter (11 mm,  0.45 m,  Mil-
ipore Millex, Billerica, USA) before injection into the HPLC system.
.9. Statistical analysis
The results are presented as mean ± SEM of three indepen-
ent experiments. Statistical signiﬁcance between the groups was
ssessed by one-way analysis of variance (ANOVA) followed by
 post hoc Newman Keuls test. The accepted level of signiﬁcance
or the test was P < 0.05. All tests were carried out using GraphPad
oftware (San Diego, CA, USA).
. Results
.1. Determination of melanin content in melanocytes
Melanogenic activity in cultured murine B16F10 melanoma cells
s directly related to the quantity of produced melanin which
s estimated through the amount of melanin retained in the
ells (intracellular melanin). Both HE increased melanin formation
Fig. 1A and B), since melanin content was found to be enhanced
n response to several concentrations of HE from leaves (0.1, 0.3,
 and 3 g/mL) and ﬂowers (0.03 and 0.1 g/mL). As depicted inas  a drug reference. Vehicle (0.02% ethanol). Data are mean ± SEM from three sep-
arate experiments. *P < 0.05, **P  < 0.01 and ***P < 0.001: statistically signiﬁcant vs.
control group (DMEM).
Fig. 1A, the HE from leaves promoted enhancement of melanogen-
esis with maximum effect of 33.3 ± 3% (3 g/mL). Similar result was
observed with HE from ﬂowers (Fig. 1B), which showed a maximum
effect of 23.4 ± 3% (0.1 g/mL). To exclude the possibility of inter-
ference of HE color in absorbance, all the concentrations of both
HE were exposed to the used wavelength and no changes were
observed when compared to the control group (phosphate saline
buffer). The same procedure was  done for the wavelengths used
in the cell viability and tyrosinase activity assay, and no alteration
was detected (data not shown).
3.2. Cell viability assay
The effect of leaves and ﬂowers extracts from P. venusta on cell
viability were measured by MTT  assay (Fig. 2). Although the vehi-
cle used with leaves extract promoted a signiﬁcant decrease in cell
viability (12.4%), the extracts did not show any additional cyto-
toxic effect on cells when compared with vehicle group. Besides,
the cytotoxicity noted with the vehicle was  not a concern since it
was not able to interfere with melanin production (Fig. 1).
3.3. Mushroom tyrosinase activity assay
Once tyrosinase is the rate-limiting enzyme for melanin biosyn-
thesis, the effect of P. venusta on tyrosinase activity was evaluated.
However, extracts did not signiﬁcantly affect the tyrosinase activity
in all tested concentrations (Fig. 3). Kojic acid a known depigment-
ing agent used as a reference drug reduced tyrosinase activity in
about 35%.
1008 C.G. Moreira et al. / Journal of Ethnopharmacology 141 (2012) 1005– 1011
Fig. 2. Effects of leaves and ﬂowers of Pyrostegia venusta on cellular viability in cul-
tured B16 murine melanoma cells. B16 cells were incubated for 96 h in the presence
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Fig. 3. Effects of leaves and ﬂowers of Pyrostegia venusta on Mushroom Tyrosinase
activity assay. Inhibition of mushroom tyrosinase activity by leaves (A) or ﬂowers (B)
extract at different concentrations. Tyrosinase activity was examined in the presencef  the leaves (A) or ﬂowers (B) extract at different concentrations. Kojic acid was
sed as a drug reference. Vehicle (0.02% ethanol). Data are mean ± SEM from three
eparate experiments. *P < 0.05: statistically signiﬁcant vs.  control group (DMEM).
.4. Allantoin content determination
To determine the allantoin content in both HE of P. venusta an
nalytical method based on HPLC/DAD was performed. The iden-
iﬁcation of allantoin was done using both the spectral analysis
UV–VIS) and comparison of the RT of allantoin standard. Addi-
ionally, this compound was identiﬁed directly in the HE by 1D and
D NMR  analyses and comparison with data reported in the liter-
ture (Ferreira et al., 2000). HE of ﬂowers and leaves of P. venusta
resented 1.08% and 0.09%, respectively, of allantoin. To quantify
llantoin in HE, a SPE clean up was carried out prior to HPLC analysis
nd the allantoin peak showed high purity (Fig. 4).
. Discussion
In this study it was evaluated the melanogenic effect of two
xtracts (leaves and ﬂowers) from P. venusta in murine B16F10
elanoma cells. This cell line has been widely used for this pur-
ose once it is relatively easy to be cultured in vitro, and has similar
elanogenic mechanisms to human melanocytes (An et al., 2008).
hen the cells were pre-treated with HE (ﬂowers and leaves) at dif-
erent concentrations, the cellular melanogenesis was signiﬁcantly
nhanced, although the same concentrations did not inﬂuence the
ctivity of tyrosinase enzyme in the cell-free assay using DOPA as
 substrate.
Recent advances in the knowledge of the pathogenesis of
itiligo have contributed to ﬁnd better treatments. Nowadays many
ffected individuals have found a way for depigmented skin with
edicinal or surgical therapies. However, progression of the dis-
ase, and partial or lack of complete repigmentation still occurs in
 larger number of patients. Further studies, with newer and moreof  l-tyrosine as substrates. It is represented as an inhibition percentage. Each value
is  given as mean ± SD from independent triplicate experiments.
potent therapies depend on the complete knowledge of vitiligo
pathogenesis (Falabella and Barona, 2009). There are few stud-
ies with plant extracts aiming to increase melanin production.
Some groups have reported the stimulation of melanogenesis by
other plants, such as citrus ﬂavonoid naringenin (Ohguchi et al.,
2006), kava (Piper methysticum) rhizome extract and kavalac-
tones (Matsuda et al., 2006), umberiferae plant extract and their
coumarin constituents (Matsuda et al., 2005), and Piper nigrum
leaves extract and their lignan constituents (Matsuda et al., 2004).
However, all these studies suggested that the active constituents
of these plants may  be useful ingredients to cosmetics for pre-
vention of white hair. Lee et al. (2007) showed that melanin
content and tyrosinase expression were increased by rosmarinic
acid in a concentration-dependent manner. Based on these results,
the authors reported that rosmarinic acid induces melanogenesis
through PKA activation signalling, and the utilization of rosmarinic
acid as a pigmenting agent might be useful for treatment of
hypopigmentation-related disorders (Lee et al., 2007).
Melanin synthesis is developed by a large number of effectors,
but the tyrosinase is the rate-limiting enzyme. Furthermore, it has
been reported other enzymes in the pathway of melanin synthesis,
including tyrosinase related proteins 1 (TRP-1) and 2 (TRP-2)
that also regulate melanogenesis (Tsukamoto et al., 1992). Other
protein kinases such as cAMP-dependent protein kinase (Korner
and Pawelek, 1977), protein kinase C-  (Gruber et al., 1992; Oka
et al., 1993) and protein kinase C- (Park et al., 1993) have been
shown to participate in the regulation of melanin synthesis in pig-
ment cells. The involvement of protein kinase C in melanogenesis
C.G. Moreira et al. / Journal of Ethnopharmacology 141 (2012) 1005– 1011 1009
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Tig. 4. HPLC chromatograms of HEs (A) ﬂowers (allantoin RT = 6.22 min), (B) leaves
hromatographic conditions: see Section 2.
till needs to be clariﬁed (Carsberg et al., 1994; Oka et al., 2000).
urthermore, mitogen-activated protein kinase has been shown to
e involved in cAMP-induced melanogenesis (Englaro et al., 1995)
nd c-kit-mediated activation of the microphthalmia-associated
ranscription factor (MITF), a trans-acting factor that regulates
he gene transcription of tyrosinase (Hemesath et al., 1998).
hus, a probable mechanism throughout P. venusta stimulatesostegia venusta (allantoin RT = 6.33 min) and (C) allantoin standard (RT = 6.22 min).
melanogenesis might be related to other enzymes involved in the
process of melanogenesis, other than tyrosinase. Moreover, it is
also possible that the extracts of P. venusta could be inducing an
increase in the expression of tyrosinase enzyme, without affecting
its activity, which would also result in a raise in melanogenesis.
The detected compound allantoin has been widely described
in the literature to have several pharmacological activities, such
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s stimulation of cell mitosis (Loots et al., 1979), analgesia
Shestopalov et al., 2006), keratolytic activity (Veraldi et al., 2008),
nti-inﬂammatory (Lee et al., 2010), antipsoriase, and immunos-
imulant, and it is widely employed in dermatology (Ferreira et al.,
000). Araujo et al. (2010) suggest that allantoin modulates the
nﬂammatory response, possibly by inhibiting the chemotaxis of
nﬂammatory cells in the site of the wound, thus preventing the
elease of reactive species responsible for the oxidative stress and
issue damage. Besides, allantoin treatment led to signiﬁcant reduc-
ion in the levels of IgE and Th2-type cytokines, such as IL-4 and IL-5,
n bronchoalveolar lavage (BAL) ﬂuid. Since allantoin is a compound
ith several pharmacological properties, including in processes of
kin disorders, it is possible that this compound could participate in
he melanogenic action of P. venusta. For these reasons its content
n the HE of leaves and ﬂowers of P. venusta was determined, and
esults show low amounts in both extracts, but for the ﬁrst time it
s described in leaves and ﬂowers of this plant.
Although this study clearly demonstrated the melanogenic
ffect of extracts of P. venusta in melanoma cells, important ques-
ions remain unclear, such as its in vivo efﬁcacy. In fact, many other
elanogenesis stimulators found in the in vitro studies failed to
how in vivo efﬁcacy, probably because they could not reach or
nter skin cells because of the stratum corneum barrier. Further
tudies are needed to directly examine whether topically applied
. venusta can enhance human skin pigmentation under physiolog-
cally relevant conditions.
. Conclusion
In summary, the present study revealed that both extracts of
. venusta (leaves and ﬂowers) stimulates cellular melanogenesis
t low concentrations, through a mechanism not yet elucidated.
hus, both extracts of P. venusta may  be a potential option for the
reatment of hypopigmentation diseases such as vitiligo. However,
dditional studies are necessary to address the mechanism of action
nd the safety of P. venusta extracts.
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